About
Attivare Therapeutics develops an AI-driven platform that personalizes immune agonist selection and delivers them via a proprietary biomaterial scaffold directly into the tumor microenvironment to activate and reprogram immune cells for cancer and infectious disease treatment.
Explore Attivare Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.